Invention Grant
- Patent Title: Tuberculosis treatment using pleuromutilin derivatives
-
Application No.: US11818094Application Date: 2007-06-13
-
Publication No.: US08088823B2Publication Date: 2012-01-03
- Inventor: Gerd Ascher , Heinz Berner , Rosemarie Mang
- Applicant: Gerd Ascher , Heinz Berner , Rosemarie Mang
- Applicant Address: AT Vienna
- Assignee: Nabriva Therapeutics AG
- Current Assignee: Nabriva Therapeutics AG
- Current Assignee Address: AT Vienna
- Agent D. Peter Hochberg; Sean F. Mellino; Daniel J. Smola
- Priority: GB0207495.3 20020328; GB0217149.4 20020724; GB0217305.2 20020725
- Main IPC: A01N37/00
- IPC: A01N37/00 ; A61K31/21
Abstract:
A method of preventing or treating diseases caused by Mycobacterium, comprising administering to a subject in need of such treatment an effective amount of a pleuromutilin.
Public/Granted literature
- US20070270404A1 Tuberculosis treatment using pleuromutilin derivatives Public/Granted day:2007-11-22
Information query
